Skip to main content
SpringerLink
Log in

Appropriate Use of Complementary and Alternative Medicine Approaches in Gynecologic Cancers

  • Gynecologic Cancers (RJ Morgan, Section Editor)
  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Gynecologic cancer patients frequently desire alternative and/or complementary interventions or medicines to aid in relief of both cancer-related and treatment-related side effects. Furthermore, women also seek treatment to aid in superior outcomes and cure rates. Unfortunately, evidence suggests that the use of complementary and/or alternative medicine (CAM) is underreported or not discussed with physicians providing cancer care. In gynecologic cancer literature, there is a lack of scientific evidence either supporting or negating CAM. Because of the lack of information available, health care providers do not have good information regarding safety, efficacy, and dose of CAM. This leads to miscommunication or absence of communication between providers and patients. Because patients do use CAM to improve quality of life (QOL) during and after treatment, it would be educational for providers to know the specific QOL deficits among patients that require attention. Thus, with the ultimate goal of improving QOL for gynecologic cancer patients, providers should be pushed to investigate CAM and determine an honest support or rejection of these therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. National Institutes of Health: National Center for Complementary and Alternative Medicine (NCCAM). Available at: http://nccam.nih.gov/health/whatiscam. Accessed September 23, 2013.

  2. American Cancer Society. Available at: http://www.cancer.org. Accessed September 23, 2013.

  3. Matulonis UA, Kornblith A, Lee H, et al. Long-term adjustment of early-stage ovarian cancer survivors. Int J Gynecol Cancer. 2008;18:1183–93.

    Article  CAS  PubMed  Google Scholar 

  4. Von Gruenigen VE, Frasure HE, Jenison EL, et al. Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy. Gynecol Oncol. 2006;103:120–6.

    Article  Google Scholar 

  5. Ferrell B, Smith S, Cullinane C, et al. Symptom concerns of women with ovarian cancer. J Pain Symptom Manag. 2003;25:528–38.

    Article  Google Scholar 

  6. Nahin RL, Barnes PM, Stussman BJ, et al. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report. 2009;18:1–14.

    PubMed  Google Scholar 

  7. Rhode JM, Patel DA, Sen A, et al. Perception and use of complementary and alternative medicine among gynecologic oncology care providers. Int J Gynaecol Obstet. 2008;203:111–5.

    Article  Google Scholar 

  8. Downey L, Tyree PT, Lafferty WE. Preventive screening of women who use complementary and alternative medicine providers. J Womens Health. 2009;18:1133–43.

    Article  Google Scholar 

  9. Navo MA, Phan J, Vaughan C, et al. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol. 2004;22:671–7.

    Article  PubMed  Google Scholar 

  10. Pineda MJ, Singh DK. What is integrative oncology and can it help my patients? Obstet Gynecol Clin North Am. 2012;39:285–312.

    Article  PubMed  Google Scholar 

  11. Lopez AJ, McCaffrey R, Quinn Griffin MT, et al. Spiritual well-being and practices among women with gynecologic cancer. Oncol Nurs Forum. 2009;36:300–5.

    Article  PubMed  Google Scholar 

  12. Greenwald HP, McCorkle R. Remedies and life changes among invasive cervical cancer survivors. Urol Nurs. 2007;27:47–53.

    PubMed  Google Scholar 

  13. Smith AR, DeSanto-Madeya S, Perez JE, et al. How women with advanced cancer pray: a report from two focus groups. Oncol Nurs Forum. 2012;39:E310–6.

    Article  PubMed  Google Scholar 

  14. Leon-Pizarro C, Gich I, Barthe E, et al. A randomized trial of the effect of training in relaxation and guided imagery techniques in improving psychological and quality-of-life indices for gynecologic and breast brachytherapy patients. Psychooncology. 2007;16:971–9.

    Article  PubMed  Google Scholar 

  15. Brotto LA, Erskine Y, Carey M, et al. A brief mindfulness-based cognitive behavioral intervention improves sexual functioning vs wait-list control in women treated for gynecologic cancer. Gynecol Oncol. 2012;125:320–5.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Kwekkeboom KL, Abbott-Anderson K, Wanta B. Feasibility of a patient-controlled cognitive-behavioral intervention for pain, fatigue, and sleep disturbance in cancer. Oncol Nurs Forum. 2010;37:E151–9.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Lutgendorf SK, Mullen-Houser E, Russel D, et al. Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach. Brain Behav Immune. 2010;24:1231–40.

    Article  Google Scholar 

  18. Chan YM, Lee PW, Ng TY, et al. The use of music to reduce anxiety for patients undergoing colposcopy: a randomized trial. Gynecol Oncol. 2003;91:213–7.

    Article  CAS  PubMed  Google Scholar 

  19. Sanchez-Ledesma MJ, Lopez-Olaondo L, Pueyo FJ, et al. A comparison of three antiemetic combinations for the prevention of postoperative nausea and vomiting. Anesth Analg. 2002;95:1590–5.

    Article  CAS  PubMed  Google Scholar 

  20. Turgut S, Ozalp G, Dikmen S, et al. Acupressure for postoperative nausea and vomiting in gynaecological patients receiving patient-controlled analgesia. Eur J Anaesthesiol. 2007;24:87–91.

    Article  CAS  PubMed  Google Scholar 

  21. Matulonis U, Campos S, Duska L, et al. A phase II trial of three sequential doublets for the treatment of advanced mullerian malignancies. Gynecol Oncol. 2003;91:293–8.

    Article  CAS  PubMed  Google Scholar 

  22. Lu W, Matulonis UA, Doherty-Gilman A, et al. Acupuncture for chemotherapy-induced neutropenia in patients with gynecologic malignancies: a pilot randomized, sham-controlled clinical trial. J Altern Complement Med. 2009;15:745–53.

    Article  PubMed  Google Scholar 

  23. Mitchell JL, Walsh J, Wang-Cheng R, et al. Postmenopausal hormone therapy: a concise guide to therapeutic uses, formulations, risks, and alternatives. Prim Care. 2003;30:671–96.

    Article  PubMed  Google Scholar 

  24. Gavronsky S, Koeniger-Donohue R, Steller J, et al. Postoperative pain: acupuncture vs percutaneous electrical nerve stimulation. Pain Manage Nurs. 2012;13:150–6.

    Article  Google Scholar 

  25. Sweet ES, Standish LJ, Goff BA, et al. Adverse events associated with complementary and alternative medicine use in ovarian cancer patients. Integr Cancer Ther. 2013;12:508–16. This study found the current literature on drug-CAM interactions to be limited, raising concerns about CAM-chemotherapy interactions and its impact on anticipated treatment outcomes given the high percentage of CAM use in ovarian cancer patients.

  26. Manusirivithaya S, Sripramote M, Tangjitgamol S, et al. Antiemetic effect of ginger in gynecologic oncology patients receiving cisplatin. Int J Gynecol Cancer. 2004;14:1063–9.

    Article  CAS  PubMed  Google Scholar 

  27. Ye B, Aponte M, Dai Y, et al. Ginkgo Biloba and ovarian cancer prevention: epidemiological and biological evidence. Cancer Lett. 2007;251:43–52.

    Article  CAS  PubMed  Google Scholar 

  28. Rees M. Gynaecological oncology perspective on management of the menopause. Eur J Surg Oncol. 2006;32:892–7.

    Article  CAS  PubMed  Google Scholar 

  29. Klein A, He X, Roche M, et al. Prolonged stabilization of platinum-resistant ovarian cancer in a single patient consuming a fermented soy therapy. Gynecol Oncol. 2006;100:205–9.

    Article  PubMed  Google Scholar 

  30. Fasching PA, Thiel F, Nicolaisen-Murmann K, et al. Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer. 2007;15:1277–84.

    Article  CAS  PubMed  Google Scholar 

  31. Chan KK, Yao TJ, Jones B, et al. The use of Chinese herbal medicine to improve quality of life in women undergoing chemotherapy for ovarian cancer: a double-blind placebo-controlled randomized trial with immunological monitoring. Ann Oncol. 2011;22:2241–9.

    Article  CAS  PubMed  Google Scholar 

  32. Del Priore G, Gudipudi DK, Montemarano N, et al. Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia. Gynecol Oncol. 2010;116:464–7.

    Article  PubMed  Google Scholar 

  33. Powell CB, Fung P, Jackson J, et al. Aqueous extract of herba Scutellaria barbatea, a Chinese herb used for ovarian cancer, induced apoptosis of ovarian cancer cell lines. Gynecol Oncol. 2003;91:332–40.

    Article  PubMed  Google Scholar 

  34. Zhu K, Fukasawa I, Furuno M, et al. Inhibitory effects of herbal drugs on the growth of human ovarian cancer cell lines through the induction of apoptosis. Gynecol Oncol. 2005;97:405–9.

    Article  PubMed  Google Scholar 

  35. Drisko JA, Chapman J, Hunter VJ. The use of antioxidant therapies during chemotherapy. Gynecol Oncol. 2003;88:434–9.

    Article  CAS  PubMed  Google Scholar 

  36. Cruciani RA, Zhang JJ, Manola J, et al. L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2012;30:3864–9.

    Article  CAS  PubMed  Google Scholar 

  37. Hershman DL, Unger JM, Crew KD, et al. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. J Clin Oncol. 2013;31:2627–33.

    Article  CAS  PubMed  Google Scholar 

  38. Newton MJ, Hayes SC, Janda M, et al. Safety, feasibility and effects of an individualized walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study. BCM Cancer. 2011;11:389.

    Google Scholar 

  39. Becker H, Jung S. Health promotion among older cancer survivors with prior disabling conditions. J Gerontol Nurs. 2012;38:38–43. This study demonstrated the benefit of exercise intervention in cancer treatment to reduce symptoms and increase QOL, supporting other recent studies (ie, LIvES) that are examining the role exercise can play as CAM in cancer treatment.

  40. Prentice RL, Thomson CA, Caan BJ, et al. Low-fat dietary pattern and cancer incidence in the Women’s Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst. 2007;99:1534–43.

    Article  PubMed Central  PubMed  Google Scholar 

  41. Anderson JP, Ross JA, Folsom AR. Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women's Health Study. Cancer. 2004;100:1515–21.

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

Dana M. Chase declares that she has no conflict of interest. Steven J. Gibson declares that he has no conflict of interest. Daniele A. Sumner declares that she has no conflict of interest. Jennifer W. Bea declares that she has no conflict of interest. David S. Alberts declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Arizona Cancer Center, Creighton University School of Medicine at St. Joseph’s Hospital and Medical Center, 500 W. Thomas Road, Suite 600, Phoenix, AZ, 85013, USA

    Dana M. Chase MD, Steven J. Gibson & Daniele A. Sumner BA

  2. Department of Medicine, The University of Arizona Cancer Center, The University of Arizona, Tucson, AZ, 85724, USA

    Jennifer W. Bea PhD & David S. Alberts MD

Authors
  1. Dana M. Chase MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven J. Gibson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniele A. Sumner BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jennifer W. Bea PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David S. Alberts MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dana M. Chase MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chase, D.M., Gibson, S.J., Sumner, D.A. et al. Appropriate Use of Complementary and Alternative Medicine Approaches in Gynecologic Cancers. Curr. Treat. Options in Oncol. 15, 14–26 (2014). https://doi.org/10.1007/s11864-013-0269-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-013-0269-x

Keywords

Search

Navigation